NTBL - Notable Labs Ltd Company Long-Term Liabilities

The daily price chart on GURU.Markets helps assess the impact of Notable Labs, Ltd. (NTBL) ESG strategies, which implement software for oncology therapy optimization and energy-efficient clouds. Notable Labs, Ltd. (NTBL) delegates IT development and testing to external contractors to focus on personalized treatment. Meanwhile, liquidity shortages and software costs necessitate external financing, with the current metric standing at 0.00.

notablelabs.com (NTBL) Company Long-Term Debt: for the period 02/21/2024 - 11/02/2024

Notable Labs Inc. (NTBL) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price notablelabs.com|NTBL - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Notable Labs|NTBL - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Notable Labs|NTBL - Company Book Value|Market Value to Book Value notablelabs.com|NTBL - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Notable Labs, Ltd.|NTBL - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Notable Labs Corp|NTBL - Company Total Debt|Debts to Book Capitalization Notable Labs|NTBL - Company Long-Term Debt|Company Short-Term Loans and Borrowings Notable Labs|Immediate Liquidity notablelabs.com
- earnings and market multiples details:
NTBL - Company Net Income
Fundamental company valuation:NTBL (notablelabs.com)

Notable Labs, Ltd. (NTBL) dependence on external financing during the development of its oncology platform makes the organization's long-term financial debt a critical indicator. This metric captures obligations with maturities exceeding one year, revealing the systemic resilience of the business. It measures the volume of borrowed capital used for scaling without immediate returns. An upward trend indicates aggressive expansion, while a decrease signals a strengthening balance sheet. It is essential for investors to correlate this debt with the pace of regulatory software approvals.

Competitors of Notable Labs, Ltd. (NTBL)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Debt TuHURA Biosciences, Inc. (HURA)|protaratx.com - Company Long-Term Indebtedness|Company Long-Term Debt Fate Therapeutics FATE|Aadi Bioscience, Inc. (WHWK) - Long-Term Debt|TCRX: Company Long-Term Liabilities|Champions Oncology - Amount of Long-Term Liabilities|XBIT: Company Long-Term Debts|CEL-SCI (CVM) - Company Long-Term Debts|OSTX (OS Therapies) - Company Long-Term Debts|Company Long-Term Debt RADX|Company Long-Term Debt Artiva Biotherapeutics, Inc. (ARTV)|Company Long-Term Debt ANL (adlainortye.com)|Company Long-Term Debts VERU (Veru Inc.)|tempesttx.com (TPST) - Long-Term Debt|XLO: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings RENB (Renovaro Inc.)|muraloncology.com (MURA) - Company Long-Term Debt|KAPA (Kairos Pharma) - Company Long-Term Debt|OKUR (OnKure Therapeutics, Inc.) - Company Long-Term Debts|Company Long-Term Debts CytoMed|Company Long-Term Debts CRIS|Company Long-Term Debt APLM (apollomicsinc.com)|Company Long-Term Debt Tharimmune Corp THAR|Long-Term Debt Volume Advanced Biomed Inc. (ADVB)|GNPX: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings CLDI (Calidi Biotherapeutics)|Sunshine Biopharma (SBFM) - Company Long-Term Debt|XBIO (Xenetic Biosciences, Inc.) - Company Long-Term Debt|Company Long-Term Liabilities SLRX|PPBT (Kitov Pharma) - Amount of Long-Term Liabilities|Company Long-Term Debts AONC|beigene.com - Company Long-Term Indebtedness|Checkpoint Therapeutics, Inc. - Company Long-Term Liabilities|Long-Term Debt Volume Elevation Oncology Inc. (ELEV)|ICAD - Company Long-Term Debt|IKNA (Ikena Oncology, Inc.) - Company Long-Term Indebtedness|VIRX (viracta.com) - Company Long-Term Liabilities|MOR: Amount of Long-Term Liabilities|NAYA (NAYA Biosciences Inc.) - Company Long-Term Debts|Company Long-Term Debt AAPGV